Literature DB >> 24988057

Management of Liver Cancer Argon-helium Knife Therapy with Functional Computer Tomography Perfusion Imaging.

Hongbo Wang1, Shengjie Shu2, Jinping Li2, Huijie Jiang3.   

Abstract

The objective of this study was to observe the change in blood perfusion of liver cancer following argon-helium knife treatment with functional computer tomography perfusion imaging. Twenty-seven patients with primary liver cancer treated with argon-helium knife and were included in this study. Plain computer tomography (CT) and computer tomography perfusion (CTP) imaging were conducted in all patients before and after treatment. Perfusion parameters including blood flows, blood volume, hepatic artery perfusion fraction, hepatic artery perfusion, and hepatic portal venous perfusion were used for evaluating therapeutic effect. All parameters in liver cancer were significantly decreased after argon-helium knife treatment (p < 0.05 to all). Significant decrease in hepatic artery perfusion was also observed in pericancerous liver tissue, but other parameters kept constant. CT perfusion imaging is able to detect decrease in blood perfusion of liver cancer post-argon-helium knife therapy. Therefore, CTP imaging would play an important role for liver cancer management followed argon-helium knife therapy.
© The Author(s) 2014.

Entities:  

Keywords:  Argon-helium knife; Computer tomography perfusion; Liver cancer

Mesh:

Year:  2014        PMID: 24988057     DOI: 10.7785/tcrt.2012.500443

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  2 in total

Review 1.  A Systematic Review on the Role of the Perfusion Computed Tomography in Abdominal Cancer.

Authors:  Nunzia Garbino; Valentina Brancato; Marco Salvatore; Carlo Cavaliere
Journal:  Dose Response       Date:  2021-11-24       Impact factor: 2.658

2.  Computed tomography-guided argon-helium cryoablation for sacrum chordoma.

Authors:  Liang Li; Xiao-Fan Jiang; Li-Jun Sun; Yu-Fei Fu; Wei Zhang
Journal:  Medicine (Baltimore)       Date:  2020-10-16       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.